126 related articles for article (PubMed ID: 2981381)
1. Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit.
Bhargava HN; Pillai NP
Life Sci; 1985 Jan; 36(1):83-8. PubMed ID: 2981381
[TBL] [Abstract][Full Text] [Related]
2. The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit.
Pillai NP; Bhargava HN
Peptides; 1984; 5(6):1055-9. PubMed ID: 6099556
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice.
Bansinath M; Bhargava HN
Neuropharmacology; 1988 Apr; 27(4):433-7. PubMed ID: 2901674
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of thyrotropin releasing hormone induced inhibition of gastrointestinal transit.
Bhargava HN; Pillai NP
Peptides; 1985; 6(2):185-7. PubMed ID: 3929234
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
Ramabadran K; Bansinath M; Turndorf H; Puig MM
Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
Pillai NP; Bhargava HN
Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
[TBL] [Abstract][Full Text] [Related]
7. Stereospecific effects of a kappa-opiate antagonist on the actions of morphine in morphine-tolerant rats.
Bhargava HN; Kremer EK; Gibbons MO; Philips BJ; Driver JW; Chou M
Eur J Pharmacol; 1989 Dec; 173(2-3):159-64. PubMed ID: 2560431
[TBL] [Abstract][Full Text] [Related]
8. Potentiation by TRH of the effect of imipramine on the forced-swimming test.
Reny-Palasse V; Rips R
Br J Pharmacol; 1985 Jun; 85(2):463-70. PubMed ID: 2992664
[TBL] [Abstract][Full Text] [Related]
9. Morphine inhibits TRH-induced intestinal transit increases.
Heitkemper MM; Bond EF
Peptides; 1990; 11(6):1113-7. PubMed ID: 2128399
[TBL] [Abstract][Full Text] [Related]
10. Relative involvement of receptor subtypes in opioid-induced inhibition of intestinal motility in mice.
Ward SJ; Takemori AE
Life Sci; 1982 Sep 20-27; 31(12-13):1267-70. PubMed ID: 6128653
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
Manara L; Bianchi G; Ferretti P; Tavani A
J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
[TBL] [Abstract][Full Text] [Related]
12. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
Porreca F; Burks TF
J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
[TBL] [Abstract][Full Text] [Related]
13. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
Gistrak MA; Paul D; Hahn EF; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
[TBL] [Abstract][Full Text] [Related]
15. Morphine antagonizes TRH-induced intestinal transit and hyperserotonemia in rabbits.
Horita A; Carino MA; Mori T
Eur J Pharmacol; 1988 Jan; 145(1):55-9. PubMed ID: 3127223
[TBL] [Abstract][Full Text] [Related]
16. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
Shook JE; Pelton JT; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
[TBL] [Abstract][Full Text] [Related]
17. The role of opiates and endogenous opioid peptides in the regulation of rat TSH secretion.
Sharp B; Morley JE; Carlson HE; Gordon J; Briggs J; Melmed S; Hershman JM
Brain Res; 1981 Aug; 219(2):335-44. PubMed ID: 6266605
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog.
Manara L; Bianchi G; Fiocchi R; Notarnicola A; Peracchia F; Tavani A
Life Sci; 1982 Sep 20-27; 31(12-13):1271-4. PubMed ID: 6183550
[TBL] [Abstract][Full Text] [Related]
19. Blockade by naloxone and naltrexone of the TRH-induced stimulation of colonic transit in the rabbit.
Horita A; Carino MA; Pae YS
Eur J Pharmacol; 1985 Feb; 108(3):289-93. PubMed ID: 3921389
[TBL] [Abstract][Full Text] [Related]
20. Ketazocines and morphine: effects on gastrointestinal transit after central and peripheral administration.
Porreca F; Cowan A; Raffa RB; Tallarida RJ
Life Sci; 1983 Apr; 32(15):1785-90. PubMed ID: 6339861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
